ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

ペントキシベリン

Carbetapentane

HCID 2562
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
77-23-6
標準SMILES
CCN(CC)CCOCCOC(=O)C1(c2ccccc2)CCCC1
InChIKey
CFJMRBQWBDQYMK-UHFFFAOYSA-N
分子式
C20H31NO3
平均分子量
333.5 g/mol
単同位体質量
333.23039385

概要

1-phenyl-1-cyclopentanecarboxylic acid 2-[2-(diethylamino)ethoxy]ethyl ester is a member of benzenes.

名称と識別子

優先名称
Carbetapentane
IUPAC
2-[2-(diethylamino)ethoxy]ethyl 1-phenylcyclopentane-1-carboxylate
現地名
ペントキシベリン
英語名
Pentoxyverine
分子式
C20H31NO3
分子量
333.46

名称と別名

carbetapentanePentoxyverine77-23-6PentoxiverinPentoxyverinAtussilPentoxiverinaPentoxyverinumSedotussin1-Phenyl-1-cyclopentanecarboxylateUCB 2543DTXSID9022734
名称をさらに表示
ペントキシベリン1-フェニルシクロペンタン-1-カルボン酸2-[2-(ジエチルアミノ)エトキシ]エチルカルベタペンタン1-フェニルシクロペンタンカルボン酸2-[2-(ジエチルアミノ)エトキシ]エチルアツッシル1-フェニルシクロペンタンカルボン酸2-(2-ジエチルアミノエトキシ)エチル CITRATE2-[2-(ジエチルアミノ)エトキシ]エチル 1-フェニルシクロペンタン-1-カルボキシラートPENTOXIFYLLINEUrexTuclasePentoxyverine Baseucb2543u.c.b.2543U.C.B. 2543
2-(2-Diethylaminoethoxy)ethyl 1-phenylcyclopentanecarboxylate2-(Diethylaminoethoxy)ethyl 1-phenyl-1-cyclopentanecarboxylate2-(Diethylaminoethoxy)ethyl 1-phenylcyclopentyl-1-carboxylate32C726X12W1-Phenylcyclopentane-1-carboxylic acid diethylaminoethoxyethyl esterEthanol, 2-(2-(diethylamino)ethoxy)-, 1-phenylcyclopentanecarboxylate (ester)DTXCID1027341-Phenylcyclopentanecarboxylic acid 2-(2-diethylaminoethoxy)ethyl ester

データベース識別子

CAS
77-23-6
PubChem CID
2562
DTXSID
DTXSID9022734
ChEMBL
CHEMBL73234
ChEBI
CHEBI:94484
UNII
32C726X12W
EC Number
201-014-1
Nikkaji
J4.198J

物性

構造計算による物性

XLogP
3.8
極性表面積
38.8 Ų
水素結合供与体数
0
水素結合受容体数
4
回転可能結合数
11
重原子数
24
形式電荷
0
複雑度
356

実験および物理化学的性質

Drugs · 2 件

Pharmaceuticals

Pharmaceuticals -> Listed in ZINC15

SolubilitySOL IN ETHYL ALC /CITRATE/
Human DrugsPharmaceuticals
Boiling Point165-170 °C @ 0.01 MM OF HG
Melting Point90-95
Collision Cross Section175.5 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]
Other Experimental PropertiesCRYSTALS; MP: 93 °C; FREELY SOL IN WATER, CHLOROFORM; SOL IN ALC, ACETONE, ETHYL ACETATE; PRACTICALLY INSOL IN ETHER, PETROLEUM ETHER, BENZENE /CITRATE/

物理化学的性質

沸点
165 · 165-170 °C (1.33Pa)
比重(密度)
1.048 · 1.048±0.06 g/cm3(Predicted)
屈折率
1.499 · 1.4990-1.5010
貯蔵温度
Refrigerator
溶解性

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

危険有害性情報

Regulatory InformationChemical: Cyclopentanecarboxylic acid, 1-phenyl-, 2-[2-(diethylamino)ethoxy]ethyl ester
Other Safety InformationIMAP assessments - Cyclopentanecarboxylic acid, 1-phenyl-, 2-[2-(diethylamino)ethoxy]ethyl ester: Environment tier I assessment

毒性情報

Human Toxicity ExcerptsDRYNESS OF MOUTH OR THROAT, FEELING OF TIGHTNESS IN CHEST, & SLIGHT DEGREE OF RESPIRATORY DEPRESSION...ALLERGIC DERMATITIS /ADVERSE EFFECT, ORAL/

安全データ

毒性
LD50 oral in rat: 150mg/kg
hs_code
2922509090
有毒物質データの
77-23-6(Hazardous Substances Data)

化学と産業

薬理情報

ATC Code · 2 件

R - Respiratory system

QR - Respiratory system

Protein BindingNo pharmacokinetic data available.
Pharmacodynamics · 1 件

Pentoxyverine induces an antitussive action. In animal studies, intraperitoneal administration of pentoxyverine inhibited citric-acid-induced cough in guinea-pigs _in vivo_. Some mice and rat studies suggest that pentoxyverine may also exert anticonvulsant activities without inducing a protective effect from NMDA-induced lethality. Protective effects against maximal electroshock-induced seizures in a dose-related fashion was also observed following either intraperitoneal or oral administration. In hERG-transfected cells, pentoxyverine inhibited the outward current of the hERG ion channel with half-maximal inhibition concentrations (IC50) of 3.0 µM. In rats receiving intrathecal administration, pentoxyverine exhibited dose-dependent spinal blockade with a more sensory-selective action over motor blockade. It induced a spinal blockade with a more sensory/nociceptive-selective action over motor blockade compared to lidocaine.

Mechanism of Action · 2 件

While the mechanism of antitussive action of pentoxyverine is not fully understood, it is thought to be mediated via sigma-1 receptors expressed in the central nervous system. Pentoxyverine acts as an agonist at sigma receptors with the Ki of 75±28 nM, as demonstrated in a competitive binding assay. The function of sigma receptors on cough suppressant activities is unclear, however these receptors are highly expressed in the nucleus tractus solitarius (NTS) of the brainstem where the afferent fibres first synapse. NTS is located very close to the cough centre in the brainstem thus may function as a ‘gate' for the cough reflex and allow sigma-1 receptor agonists to modulate afferent activity prior to reaching the cough center. It is suggested that highly lipophilic sigma-1 agonists may penetrate the CNS following systemic administration. When administered as aerosols, sigma-1 receptor agonists may temporarily act in the periphery to modulate cough by acting activate sigma receptors expressed in the lungs. However there is limited evidence of peripheral localization of the sigma agonists following aerosol administration and the ruling out of systemic exposure. The local anesthesia action of pentoxyverine may occur through inhibition of voltage-gated Na(+) currents.

関連反応

0 件
反応記録を作成
関連する反応はまだありません

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
ジクロロメタン(微量)、メタノール(微量)
酸解離定数(Pka)
9.69 · 9.69±0.25(Predicted)
外見
油
色
クリアベリーダークレッドからブラウン
CAS データベース
77 · 77-23-6(CAS DataBase Reference)
NISTの化学物質情報
1 · 1-Cyclopentanecarboxylate, 2-(diethylaminoethoxy)ethyl-1-phenyl-(77-23-6)

NUMBER OF DRUGS ARE KNOWN TO REDUCE COUGH AS RESULT OF THEIR CENTRAL ACTIONS, ALTHOUGH EXACT MECHANISMS ARE STILL NOT ENTIRELY CLEAR. /NONOPIOID ANTITUSSIVES/

Biological Half-LifeThe half-life is 2.3 hours following oral dosing.
Metabolism/MetabolitesNo pharmacokinetic data available.
MeSH Pharmacological ClassificationAgents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally.
Absorption, Distribution and Excretion · 4 件

In humans, maximum plasma concentrations are achieved 1.2 hours after oral dosing.

No pharmacokinetic data available.

No pharmacokinetic data available.

No pharmacokinetic data available.

用途と製造

Uses · 2 件

MEDICATION

Use (kg; approx.) in Germany (2009): >1000

Methods of ManufacturingMORREN, BRITISH PATENT 753,799 (1956).
Formulations/PreparationsCARBETAPENTANE CITRATE /PRC: WITH CITRATE 1:1, TOCLASE & TUCLASE/. SYRUP, 7.25 MG/5 ML. SYRUP 7.25 MG, WITH TERPIN HYDRATE 16.7 MG, & CHLOROFORM 2.5 MG/5 ML (TOCLASE EXPECTORANT).
Use ClassificationPharmaceuticals

応用分野

使用Carbetapentane is an antitussive anticonvulsant sigma site agonist.

上流・下流製品情報

上流原料

1-フェニルシクロペンタンカルボン酸クロリド1-フェニル-1-シクロペンタンカルボン酸phenylacetonitrileセサモールジクロロカルシウムトリクロロエチレンジエチルアミン1,4-ジブロモブタン1-フェニル-1-シクロペンタンカルボニトリル2-(2-ジエチルアミノエトキシ)エタノールナトリウムアミド塩化スルフィニル